LYSOCLEAR
Lysoclear, Inc. is a pre-clinical Ichor Therapeutics portfolio company that develops enzyme therapies for eye disease. The company is currently developing leads to treat atrophic “dry” age-related macular degeneration and Stargardt’s macular degeneration.
LYSOCLEAR
Industry:
Biotechnology Life Science
Founded:
2016-01-01
Address:
Lafayette, Louisiana, United States
Country:
United States
Website Url:
http://www.lysoclear.com
Total Employee:
1+
Status:
Active
Contact:
(518) 420-5004
Total Funding:
3 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS Google Google Cloud AWS Global Accelerator WP Engine
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Investors List
Grapeseed.Bio
Grapeseed.Bio investment in Venture Round - Lysoclear
KIZOO Technology Capital
KIZOO Technology Capital investment in Seed Round - Lysoclear
Official Site Inspections
http://www.lysoclear.com
- Host name: 178.108.62.166.host.secureserver.net
- IP address: 166.62.108.178
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
